Xcout Intel
Alumis Inc.
Alumis is a late-stage biopharmaceutical company developing next-generation targeted therapies with the potential to significantly improve patient health.
Subscribe to see Alumis Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alumis Inc. at a glance
Alumis Inc. is a biotech company headquartered in South San Francisco, United States. It is publicly listed (ALMS) with a market capitalisation of $867.2M. Xcout tracks 30 named people at Alumis Inc., including Martin Babler (President, Chief Executive Officer & Chairman). Xcout recorded 9 job postings from Alumis Inc. in the last 90 days.
Alumis Inc. leadership
- Martin BablerPresident, Chief Executive Officer & Chairman
- John R. SchroerChief Financial Officer
- John SchroerChief Financial Officer
- David GoldsteinChief Scientific Officer
- Jorn DrappaChief Medical Officer & Head of Research and Development
- Roy C. HardimanChief Business & Strategy Officer
24 more named people on record for Alumis Inc., with roles, board committees and tenure — see the full roster →
Hiring at Alumis Inc.
Xcout recorded 9 job postings from Alumis Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alumis Inc.'s hiring signals →
Recent Alumis Inc. news
3 corporate events on record, with sources — see the full timeline →
Alumis Inc. competitors
A few of Alumis Inc.'s closest competitors — see the full list of competitors and alternatives →
Coherus BioSciences, Inc. is a biopharmaceutical company headquartered in Redwood City, California, focused on oncology and developing innovative therapeutics.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Lindus Therapeutics is a next-generation biopharmaceutical and drug development company registered in England and Wales, utilizing AI-driven approaches to advance portfolios of in-licensed assets.
Altimmune, Inc. is a clinical-stage biotechnology company based in California, USA, focused on developing immune-targeting therapies.
AUM Biosciences is a clinical-stage biotechnology company that develops precision oncology therapeutics utilizing multi-faceted inhibition strategies to overcome cancer drug resistance. The company serves patients and the healthcare sector by advancing a targeted clinical pipeline designed to combat tumor evasion and treatment resistance.
Get Alumis Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Alumis Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Alumis Inc. in Xcout Intel
- 30 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access